82 related articles for article (PubMed ID: 7852511)
1. The serotonin-4 receptor agonist cisapride and angiotensin-II exert additive effects on aldosterone secretion in normal man.
Lefebvre H; Contesse V; Delarue C; Legrand A; Kuhn JM; Vaudry H; Wolf LM
J Clin Endocrinol Metab; 1995 Feb; 80(2):504-7. PubMed ID: 7852511
[TBL] [Abstract][Full Text] [Related]
2. Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.
Lefebvre H; Dhib M; Godin M; Contesse V; Delarue C; Rieu M; Wolf LM; Vaudry H; Kuhn JM
Neuroendocrinology; 1997 Sep; 66(3):229-33. PubMed ID: 9380281
[TBL] [Abstract][Full Text] [Related]
3. Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers.
Lefebvre H; Gonzalez KN; Contesse V; Delarue C; Vaudry H; Kuhnl JM
Endocr Res; 1998; 24(3-4):749-52. PubMed ID: 9888571
[TBL] [Abstract][Full Text] [Related]
4. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies.
Lefebvre H; Cartier D; Duparc C; Lihrmann I; Contesse V; Delarue C; Godin M; Fischmeister R; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 2002 Mar; 87(3):1211-6. PubMed ID: 11889190
[TBL] [Abstract][Full Text] [Related]
5. Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
Lefebvre H; Cartier D; Duparc C; Contesse V; Lihrmann I; Delarue C; Vaudry H; Fischmeister R; Kuhn JM
Endocr Res; 2000 Nov; 26(4):583-7. PubMed ID: 11196433
[TBL] [Abstract][Full Text] [Related]
6. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats.
Roesch DM; Tian Y; Zheng W; Shi M; Verbalis JG; Sandberg K
Endocrinology; 2000 Dec; 141(12):4629-36. PubMed ID: 11108277
[TBL] [Abstract][Full Text] [Related]
7. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
8. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies.
Lefebvre H; Contesse V; Delarue C; Soubrane C; Legrand A; Kuhn JM; Wolf LM; Vaudry H
J Clin Endocrinol Metab; 1993 Dec; 77(6):1662-6. PubMed ID: 8263156
[TBL] [Abstract][Full Text] [Related]
9. A potential role for phospholipase-D in the angiotensin-II-induced stimulation of aldosterone secretion from bovine adrenal glomerulosa cells.
Bollag WB; Barrett PQ; Isales CM; Liscovitch M; Rasmussen H
Endocrinology; 1990 Sep; 127(3):1436-43. PubMed ID: 1696885
[TBL] [Abstract][Full Text] [Related]
10. Effect of cisapride, a serotonin-4 receptor agonist, on aldosterone secretion: absence of age-related change.
Huang YY; Hsu BR; Tsai JS
J Clin Pharmacol; 1997 Dec; 37(12):1146-9. PubMed ID: 9506010
[TBL] [Abstract][Full Text] [Related]
11. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
Carey RM; Vaughan ED; Peach MJ; Ayers CR
J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic regulation of adrenocortical function.
Lefebvre H; Contesse V; Delarue C; Vaudry H; Kuhn JM
Horm Metab Res; 1998; 30(6-7):398-403. PubMed ID: 9694569
[TBL] [Abstract][Full Text] [Related]
13. Rat model for investigating ACTH-independent angiotensin-induced aldosterone secretion.
Roesch DM; Tian Y; Verbalis JG; Sandberg K
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):36-9. PubMed ID: 11967797
[TBL] [Abstract][Full Text] [Related]
14. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
Williams GH; Hollenberg NK; Brown C; Mersey JH
J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition of aldosterone secretion by adrenocorticotropin.
Aguilera G; Fujita K; Catt KJ
Endocrinology; 1981 Feb; 108(2):522-8. PubMed ID: 6256154
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.
Hollenberg NK; Chenitz WR; Adams DF; Williams GH
J Clin Invest; 1974 Jul; 54(1):34-42. PubMed ID: 4365595
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced aldosterone stimulation in man is not dependent upon adrenocorticotropin.
Nicholls MG; Grekin RJ; Padfield PL
J Clin Endocrinol Metab; 1980 Nov; 51(5):1171-4. PubMed ID: 6252231
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 potentiation of angiotensin II stimulation of aldosterone production.
Cozza EN; Chiou S; Gomez-Sanchez CE
Am J Physiol; 1992 Jan; 262(1 Pt 2):R85-9. PubMed ID: 1310239
[TBL] [Abstract][Full Text] [Related]
19. Effects of K+ channel blockers on K+ channels, membrane potential, and aldosterone secretion in rat adrenal zona glomerulosa cells.
Lotshaw DP
Endocrinology; 1997 Oct; 138(10):4167-75. PubMed ID: 9322926
[TBL] [Abstract][Full Text] [Related]
20. l-Lysine Acts as a Serotonin Type 4 Receptor Antagonist to Counteract In Vitro and In Vivo the Stimulatory Effect of Serotonergic Agents on Aldosterone Secretion in Man.
Duparc C; André C; Ménard J; Godouet-Getti B; Wils J; Cailleux AF; Moreau-Grangé L; Louiset E; Lefebvre H
Horm Metab Res; 2017 Apr; 49(4):269-275. PubMed ID: 28103616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
